Results 21 to 30 of about 549 (152)

Modified Canaloplasty in the Treatment of Neovascular Glaucoma coexisting angle-closure

, 2017
This case report presents a modified canaloplasty surgery in the treatment of neovascular glaucoma(NVG) coexisting angle-closure. We combine canaloplasty with trabeculectomy as a bleb-free surgical option for lowering intraocular pressure and call this ...
Qu, Jia, Cong, Ye, Liang, Yuan Bo, Hu, Cheng   +3 more
core   +4 more sources

A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty [PDF]

Clinical Ophthalmology, 2018
Mahmoud A Khaimi Dean McGee Eye Institute, Oklahoma City, OK, USA Background: While loteprednol etabonate (LE) suspension 0.5% is approved for the treatment of postoperative ocular inflammation, there have been no reported studies of its use in ...
Khaimi MA
doaj   +2 more sources

A case of acquired external auditory canal stenosis following trauma

Indian Journal of Health Sciences and Biomedical Research KLEU, 2021
Acquired external auditory canal (EAC) stenosis is a rare clinical condition. Infection is most common cause which cause acquired EAC stenosis. Trauma is a rare cause.
Soumick Ranjan Sahoo, Mandira Sarma
doaj   +1 more source

Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation [PDF]

, 2021
Purpose This study assesses short-term intraocular pressure (IOP) change in the fellow eye of glaucoma patients after mitomycin C–augmented trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation in the treated eye.
Schuster, Alexander K., Hoffmann, Esther M., Chronopoulos, Panagiotis, Aghayeva, Fidan A., Pfeiffer, Norbert   +4 more
core   +2 more sources

Hydrus Microstent implantation with OMNI Surgical System Ab interno canaloplasty for the management of open-angle glaucoma in phakic patients refractory to medical therapy

American Journal of Ophthalmology Case Reports, 2023
Purpose: To report a series of 8 phakic eyes of 8 patients with open angle glaucoma with uncontrolled intraocular pressure on maximum tolerable medical therapy receiving Hydrus Microstent implants combined with concomitant OMNI Surgical System ab interno
Jack Creagmile, Won I. Kim, Christian Scouarnec   +2 more
doaj   +1 more source

Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma?

, 2022
PURPOSE: Myopic glaucoma patients display a considerable risk of complications following antiglaucomatous filtering surgery, e.g., trabeculectomy. Canaloplasty with mitomycin C may reduce this risk by avoiding massive overfiltration.
Lappas, Alexandra, Dietlein, Thomas Stefan, Dooling, Vivienne, Alexandra Lappas, Vivienne Dooling, Thomas Stefan Dietlein   +5 more
core   +1 more source

Clinical outcomes of the PAUL® glaucoma implant for secondary glaucoma

Acta Ophthalmologica, EarlyView.
Abstract Purpose Secondary glaucoma encompasses a broad spectrum of disease entities arising from diverse ocular pathologies and is often refractory to conventional treatment. Glaucoma drainage devices (GDDs) have therefore become an important surgical option.
Carolin Deubel, Benjamin Aretz, Wolfgang Walz, Michael Petrak, Frank G. Holz, Raffael Liegl, Karl Mercieca, Constance Liegl   +7 more
wiley   +1 more source

Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa

Pediatric Dermatology, EarlyView.
ABSTRACT Background/Objectives Recessive dystrophic epidermolysis bullosa inversa (RDEB‐I) is a rare subtype of dystrophic epidermolysis bullosa (EB) characterized by intertriginous cutaneous involvement and frequent mucosal disease. Although mucosal involvement is recognized in RDEB‐I, its cumulative clinical burden remains poorly defined.
Valerie R. Stichert, Nichole Halliburton, Sarah Crawford, Jennifer Phillips, Kalyani S. Marathe, Beth A. Moeves   +5 more
wiley   +1 more source

Clinical Results of Ab Interno Canaloplasty in Patients with Open-Angle Glaucoma

Clinical Ophthalmology, 2020
Trevor Hughes,1 Matthew Traynor2 1Brigham Young University, Rexburg, ID, USA; 2Premier Eye Care of Eastern Idaho, Idaho Falls, ID, USACorrespondence: Matthew TraynorPremier Eye Care of Eastern Idaho, Idaho Falls, ID, USATel +1 208 529-6600Email ...
Hughes T, Traynor M
doaj  

Dementia Risk After Glaucoma Surgery and Medical Therapy: A Multicentre Real‐World Cohort Study

International Journal of Geriatric Psychiatry, Volume 41, Issue 9, September 2026.
ABSTRACT Background and Purpose Glaucoma, a neurodegenerative optic neuropathy and leading cause of irreversible vision loss, shares vascular and neurodegenerative mechanisms with dementia. The 2024 Lancet Commission newly identified visual impairment as a modifiable dementia risk factor.
Lee‐Yuan Lin, Jie‐Syuan Wu, Wei‐Jung Jeng, Chen‐Hsin Tsai, Shu‐Yu Liu, Tsai‐Wei Huang, Fara Silvia Yuliani, Shyh‐Hsiang Lin   +7 more
wiley   +1 more source